Publications

Exploiting the Potential of Rivastigmine-Melatonin Derivatives as Multitarget Metal-Modulating Drugs for Neurodegenerative Diseases

AuthID
P-017-1S9

Author(s)

Dias, I

Bon, L

Banas, A

Chavarria, D

Borges, F

Guerreiro-Oliveira, C

Cardoso, SM

Sanna, D

Garribba, E

Chaves, S

Santos, MA

Document Type

Article

Year published

2025

Published

in JOURNAL OF INORGANIC BIOCHEMISTRY, ISSN: 0162-0134

Volume: 262, Pages: 112734 (15)

Indexing

Wos^®

Scopus^®

Crossref^®

Pubmed^®

Unpaywall^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.jinorgbio.2024.112734

Pubmed: 39378762

SCOPUS: 2-s2.0-85205542899

Unpaywall: 10.1016/j.jinorgbio.2024.112734

Wos: WOS:001332143900001

Source Identifiers

ISSN: 0162-0134

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Exploiting the Potential of Rivastigmine-Melatonin Derivatives as Multitarget Metal-Modulating Drugs for Neurodegenerative Diseases

Useful Links

Get Help

Federated Authentication (Click on the image)

Exploiting the Potential of Rivastigmine-Melatonin Derivatives as Multitarget Metal-Modulating Drugs for Neurodegenerative Diseases

Useful Links

Get Help